Max Healthcare Institute Ltd Analyst Rating
based on 20 analysts
60.00%
Buy
15.00%
Hold
25.00%
Sell
Based on 20 analysts offering long term price targets for Max Healthcare Institute Ltd. An average target of ₹1084.75
Source: S&P Global Market Intelligence
Max Healthcare Institute Ltd Share analysis
Max Healthcare Institute Ltd price forecast by 20 analysts
Upside of6.43%
High
₹1250
Target
₹1084.75
Low
₹615
Max Healthcare Institute Ltd target price ₹1084.75, a slight upside of 6.43% compared to current price of ₹1034.35. According to 20 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Max Healthcare Institute Ltd revenue growth forecast
Expected growth rate Q1, FY2026:85.22%
Forecast
Actual
Including amortisation and stock based compensations
Max Healthcare Institute Ltd EPS growth forecast
EPS estimate Q1, FY2026:78.86%
Forecast
Actual
Source: S&P Global Market Intelligence
Max Healthcare Institute Ltd Performance
Day's Low
Day's High
₹1,024.05₹1,048.4552 Week's Low
52 Week's High
₹610₹1,118
| Returns % | |
| 1 Month Return | -1.68 % |
| 3 Month Return | + 16.91 % |
| 1 Year Return | + 47.41 % |
| Market Stats | |
| Previous Close | ₹1,019.20 |
| Open | ₹1,027.90 |
| Volume | 25.90L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹99,079.70Cr |
Max Healthcare Institute Ltd Key Statistics
| P/E Ratio | 93.5 |
| PEG Ratio | 131.7 |
| Market Cap | ₹99,079.70 Cr |
| P/B Ratio | 10.38 |
| EPS | 10.88 |
| Dividend Yield | 0.18 |
| Sector | Healthcare |
| ROE | 9.34 |
Max Healthcare Institute Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹99,079.70 Cr | 162.41% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
| BUY | ₹51,106.89 Cr | 78.14% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
| BUY | ₹1,01,595.36 Cr | 80.62% | 0.65 | ₹917 Cr | ₹19,059 Cr | |
| BUY | ₹25,661.59 Cr | 64.52% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
| BUY | ₹24,106.37 Cr | 40.43% | 0.58 | ₹336 Cr | ₹2,498 Cr |
Max Healthcare Institute Ltd Mutual Fund Holdings
About Max Healthcare Institute Ltd
Max Healthcare Institute Ltd is one of the top healthcare providers in India, offering a wide range of products and services. Its top products include diagnostic services, medical imaging, laboratory testing, and surgical services. The company also offers a range of popular brands such as Max Super Specialty Hospital, Max Multi Specialty Centre, Max Smart Super Specialty Hospital, and Max Healthcare.
Share Price: ₹1034.35 per share as on 03 Dec, 2024 04:01 PM
Market Capitalisation: ₹99,079.70Cr as of today
Revenue: ₹1,707.46Cr as on September 2024 (Q3 24)
Net Profit: ₹281.81Cr as on September 2024 (Q3 24)
Listing date: 20 Aug, 2020
Chairperson Name: Abhay Soi
| Organisation | Max Healthcare Institute Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Max Healthcare Institute Ltd
Max Healthcare Market Cap Surpasses ₹90,000 Crore - 30 Nov, 2024
Max Healthcare Institute Ltd's market capitalization has exceeded ₹90,000 crore. Major stakeholders include FIIs and FPIs like GIC, GQG Partners, and Blackrock, while the Soi-led promoter group holds a 23.74% stake as of March 31.Max Healthcare Reports Strong Q2 Performance and Outlook - 25 Nov, 2024
Max Healthcare Institute Ltd. reported impressive Q2FY25 results, driven by strategic expansions and improved operating metrics. Analysts are optimistic about the stock's potential.Max Healthcare Shares Show Mixed Signals - 22 Nov, 2024
Max Healthcare shares rose 0.94% to Rs 999.05, with a high of Rs 1006.00. Technical indicators suggest a bearish bias, with the stock trading below the MACD signal line. The RSI stands at 50.4, indicating neutral momentum. Return on equity is at 12.68%, reflecting moderate profitability.Max Healthcare Stock Performance on November 17, 2024 - 17 Nov, 2024
On November 17, 2024, Max Healthcare Institute's stock closed at ₹1,006.25, gaining 0.43%. It remains 16.69% below its 52-week high and 70.50% above its low, indicating a stable trading range.Max Healthcare Completes Jaypee Hospital Acquisition - 12 Nov, 2024
Max Healthcare Institute has completed the acquisition of Jaypee Healthcare, gaining full control and boosting its presence in the NCR region. The stock rose 4% following the announcement.Max Healthcare Target Price Raised Amid Growth Prospects - 11 Nov, 2024
Max Healthcare Institute's EBITDA grew 14% YoY, with strong expansion plans and operational efficiency. Despite a revenue decline from Bangladesh, the outlook remains positive, leading to a target price increase to Rs 1,200.Max Healthcare Plans Major Expansion and Reports Growth - 08 Nov, 2024
Max Healthcare Institute Ltd. plans to invest Rs 6,000 crore over three years to expand its network and increase bed capacity to 9,000. The company reported a 25.3% revenue increase and a 1.9% rise in net profit in Q2, alongside recent acquisitions of Jaypee Hospitals and two others in Lucknow and Nagpur.Max Healthcare Reports Profit and Growth Projections - 07 Nov, 2024
Max Healthcare announced a Q2 net profit of Rs 281.81 crore, reflecting a 1.9% increase. The company also projects growth in revenue per bed, driven by improved occupancy and operational efficiencies.Max Healthcare Reports Strong Q2 Financial Results - 06 Nov, 2024
Max Healthcare Institute's Q2 FY25 results show a 1.9% increase in profit to Rs 281.81 crore and a 25.3% rise in revenue to Rs 1,707.46 crore, driven by improved patient mix and specialty services.
Insights on Max Healthcare Institute Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 56.98% to 57.29% in Sep 2024 quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, MAXHEALTH has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
- POSITIVE IMPACT
Price Rise
In the last 3 months, MAXHEALTH stock has moved up by 16.9%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 236.27 Cr → 281.81 Cr (in ₹), with an average increase of 16.2% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 1.38K Cr → 1.74K Cr (in ₹), with an average increase of 7.6% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 74.8% return, outperforming this stock by 27.4%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 23.74% of holdings in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 3.91% to 3.83% in Sep 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 12.19% to 11.56% in Sep 2024 quarter
Max Healthcare Institute Ltd Financials
Index Inclusions
Max Healthcare Institute Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 23.74% | ||
| Foreign Institutions | 57.29% | 0.54 | |
| Mutual Funds | 11.56% | ||
| Retail Investors | 3.83% | ||
| Others | 3.58% | 12.68 |
Max Healthcare Institute Ltd Key Indicators
Max Healthcare Institute Ltd Valuation
Max Healthcare Institute Ltd in the last 5 years
Lowest (-108.44x)
June 23, 2021
Today (93.50x)
December 2, 2024
Industry (98.85x)
December 2, 2024
Highest (114.93x)
September 16, 2021
Max Healthcare Institute Ltd Earnings and Dividends
Max Healthcare Institute Ltd Earnings Results
Max Healthcare Institute Ltd’s net profit jumped 1.85% since last year same period to ₹281.81Cr in the Q2 2024-2025. On a quarterly growth basis, Max Healthcare Institute Ltd has generated 19.27% jump in its net profits since last 3-months.
Read More about Earnings ResultsMax Healthcare Institute Ltd Dividends May,2024
In the quarter ending March 2024, Max Healthcare Institute Ltd has declared dividend of ₹1.50 - translating a dividend yield of 0.15%.
Read More about Dividends
Max Healthcare Institute Ltd Technicals Summary
Bearish
Neutral
Bullish
Max Healthcare Institute Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Max Healthcare Institute Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Max Healthcare Institute Ltd shares.
Max Healthcare Institute Ltd (MAXHEALTH) share price today is ₹1034.35
Max Healthcare Institute Ltd is listed on NSE
Max Healthcare Institute Ltd is listed on BSE
- Today’s highest price of Max Healthcare Institute Ltd is ₹1048.45.
- Today’s lowest price of Max Healthcare Institute Ltd is ₹1024.05.
PE Ratio of Max Healthcare Institute Ltd is 93.5
PE ratio = Max Healthcare Institute Ltd Market price per share / Max Healthcare Institute Ltd Earnings per share
Today’s traded volume of Max Healthcare Institute Ltd(MAXHEALTH) is 25.90L.
Today’s market capitalisation of Max Healthcare Institute Ltd(MAXHEALTH) is ₹99079.7Cr.
| Max Healthcare Institute Ltd(MAXHEALTH | Price |
|---|---|
52 Week High | ₹1118 |
52 Week Low | ₹610 |
Max Healthcare Institute Ltd(MAXHEALTH) share price is ₹1034.35. It is down -7.48% from its 52 Week High price of ₹1118
Max Healthcare Institute Ltd(MAXHEALTH) share price is ₹1034.35. It is up 69.57% from its 52 Week Low price of ₹610
| Max Healthcare Institute Ltd(MAXHEALTH | Returns |
|---|---|
1 Day Returns | 15.15% |
1 Month Returns | -1.68% |
3 Month Returns | 16.91% |
1 Year Returns | 47.41% |